Medical assistance company Credihealth on 11 July announced the launch of a medical loan facility on its platform.
The company announced its partnership with leading banks and NBFCs - as well as leading fintech players like Rubique for this endeavor, and is in talks with other financial services players for the same.
Users can now apply for medical loans via Credihealth and make paperless in-principal transactions to avail loans ranging from Rs. 30,000 to Rs. 50 lakh, for a tenure starting from six months to 48 months.
Credihealth envisions creating a favorable environment where healthcare is more accessible, affordable and actionable for millions of people around the country. To accomplish this goal, it has ensured that those in need get the much-needed financial assistance at a very competitive price.
Underlining this proposition is Credihealth's partnership with Rubique. The tie-up gives it access to Rubique's advanced technology platform, network of 65+ financial institution tie-ups, and strong distribution across 29 cities.
Credihealth expects reaching out to a much larger audience with its unique healthcare proposition through the partnership, and will also benefit from fulfillment support enabled through Rubique's fulfillment centers. For its future tie-ups as well, it is focused on teaming up with only those financial services players that are highly transparent and give loans at attractive and fair rates.
"Credihealth is making it convenient for patients to pay their medical bills through an EMI model. We are also leveraging our superior network of service providers and procurement supply chain to reduce the overall cost of care in the ecosystem," said founder and MD Credihealth, Ravi Virmani.
"This association will allow us to enable quick and hassle-free medical loans to millions of Indians in need of healthcare services through our state-of-the-art, innovative platform. We are confident that our mutual synergies will help in making quality healthcare more accessible to a larger part of the country's population," said MD and CEO Rubique, Manav Jeet.